Unidad de Cefaleas y Neuralgias, Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
Unidad de Neurocirugía Funcional, Servicio de Neurocirugía, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
Med Clin (Barc). 2020 Feb 14;154(3):75-79. doi: 10.1016/j.medcli.2019.03.023. Epub 2019 Nov 18.
Cluster headache (CR) is the most severe human headache and is chronic in 10%-20% of patients, and 10% can become refractory to all effective drugs. In this scenario, surgical procedures are indicated: radiofrequencies of the sphenopalatine ganglion ipsilateral to pain (RF-SPG), bilateral stimulation of the occipital nerves (NOM-S) and deep brain stimulation (DBS) of the ipsilateral posterior hypothalamus. The efficacy and safety of each of these procedures has been specifically analyzed, but the progress of a series of patients following this surgical route in order of aggressiveness has not been described.
Patients with chronic and refractory CR according to the criteria of the European Headache Federation. The patients underwent RF-SPG, NOM-S sequentially if the previous procedure had been ineffective, and DBS if the previous procedure had been ineffective.
We prospectively included 44 patients between November 2003 and June 2018 with an average age of 38.3 years; 70% were men. The mean follow-up was 87.4 months. Nineteen patients responded to 74 procedures of RF-SPG (33.3%). Of the remaining 25 patients, a NOM-S device was implanted in 22, showing an efficacy of 50%. Finally, 9 patients underwent ECP of the ipsilateral lower-posterior hypothalamus with an efficacy of 88.8%. No serious complications were found following any of these 3 procedures.
The sequential application of these three surgical procedures succeeded in reversing the serious situation of chronic CR refractory to an episodic CR in 93% of patients with acceptable surgical morbidity.
丛集性头痛(CR)是最严重的人类头痛,10%-20%的患者为慢性头痛,其中 10%的患者对所有有效药物均产生抵抗。在这种情况下,需要进行手术治疗:同侧翼腭神经节射频热凝术(RF-SPG)、双侧枕神经刺激术(NOM-S)和同侧下丘脑后部的深部脑刺激术(DBS)。这些手术的有效性和安全性已得到专门分析,但尚未描述按照侵袭性顺序对一系列患者进行这一系列手术的进展情况。
根据欧洲头痛联合会的标准,患有慢性和难治性 CR 的患者。如果先前的手术无效,患者将接受 RF-SPG 和 NOM-S 治疗;如果先前的手术无效,将接受 DBS 治疗。
我们前瞻性纳入了 2003 年 11 月至 2018 年 6 月期间的 44 例患者,平均年龄为 38.3 岁;70%为男性。平均随访时间为 87.4 个月。19 例患者对 74 次 RF-SPG 治疗有反应(33.3%)。在其余 25 例患者中,22 例植入了 NOM-S 装置,有效率为 50%。最后,9 例患者接受了同侧下丘脑后下部 ECP,有效率为 88.8%。这 3 种手术均未出现严重并发症。
这 3 种手术的序贯应用成功地使 93%的慢性 CR 患者的严重情况得到逆转,这些患者对发作性 CR 产生抵抗,且手术发病率可接受。